← Back to Screener
BioHarvest Sciences Inc. Common Stock (BHST)
Price$3.19
Value ScoreD
Growth ScoreA
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-21.65%
Price vs S&P 500 (4W)-11.69%
VGM Score55.72
Market Capitalization$123.96M
All Metrics
Book Value / Share (Quarterly)$0.24
Revenue Growth (3Y)217.48%
Cash Flow / Share (Quarterly)$-0.58
Price vs S&P 500 (YTD)0.00%
Gross Margin (TTM)54.00%
Net Profit Margin (TTM)-76.65%
EPS (TTM)$-1.19
10-Day Avg Trading Volume0.00M
EPS Excl Extra (TTM)$-1.19
EPS (Annual)$-0.93
ROI (Annual)-178.22%
Gross Margin (Annual)44.45%
Cash / Share (Quarterly)$0.16
Revenue Growth QoQ (YoY)101.88%
ROA (Last FY)-96.27%
Revenue Growth TTM (YoY)111.68%
EBITD / Share (TTM)$-0.44
Operating Margin (TTM)-35.00%
Cash Flow / Share (Annual)$-0.02
P/B Ratio29.95x
P/B Ratio (Quarterly)32.45x
Net Income / Employee (Annual)$-141,200
EV / Revenue (TTM)5.88x
Net Interest Coverage (TTM)-11.14x
ROA (TTM)-85.16%
EPS Incl Extra (Annual)$-0.93
Current Ratio (Annual)1.94x
Quick Ratio (Quarterly)0.48x
3-Month Avg Trading Volume0.00M
52-Week Price Return-46.88%
Revenue / Employee (TTM)$252,000
Tangible BV / Share (Quarterly)$-0.02
P/S Ratio (Annual)9.78x
Asset Turnover (Annual)0.21x
52-Week High$8.05
EPS Excl Extra (Annual)$-0.93
26-Week Price Return-20.93%
Quick Ratio (Annual)1.62x
Total Debt / Equity (Annual)0.93x
Current Ratio (Quarterly)0.80x
Enterprise Value$131.89M
Asset Turnover (TTM)1.11x
Revenue / Employee (Annual)$142,400
Inventory Turnover (Annual)3.71x
Pretax Margin (Annual)-99.15%
Cash / Share (Annual)$0.01
Net Income / Employee (TTM)$-193,200
ROE (Last FY)-344.20%
Net Interest Coverage (Annual)-0.58x
EPS Basic Excl Extra (Annual)$-0.93
Receivables Turnover (TTM)14.40x
Total Debt / Equity (Quarterly)2.58x
EPS Incl Extra (TTM)$-1.19
Receivables Turnover (Annual)4.32x
ROI (TTM)-21.15%
P/S Ratio (TTM)5.53x
Revenue / Share (Annual)$0.94
Tangible BV / Share (Annual)$-0.02
Price vs S&P 500 (52W)-46.24%
Year-to-Date Return0.00%
5-Day Price Return-0.63%
EPS Normalized (Annual)$-0.93
Net Profit Margin (Annual)-99.15%
Month-to-Date Return0.00%
Cash Flow / Share (TTM)$-0.03
EBITD / Share (Annual)$-0.71
Operating Margin (Annual)-78.65%
EPS Basic Excl Extra (TTM)$-1.19
P/B Ratio (Annual)73.09x
Inventory Turnover (TTM)3.92x
Pretax Margin (TTM)-76.65%
Book Value / Share (Annual)$0.01
Price vs S&P 500 (13W)-1.33%
Beta-0.34x
Revenue / Share (TTM)$1.29
ROE (TTM)-62.28%
52-Week Low$7.95
vGradeD
gGradeA
mGradeC
vgmGradeC
Show chart for
Analyst Recommendations
Jan 2025
Feb 2025
Mar 2025
Apr 2025
4.14
4.13
4.13
4.13
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BHSTBioHarvest Sciences Inc. Common Stock | D | A | C | $3.19 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
BioHarvest Sciences owns patented technology for large-scale plant cell cultivation that produces active plant ingredients directly, without growing whole plants. The company operates across two segments: nutraceuticals such as dietary supplements and botanical-derived Active Pharmaceutical Ingredients for therapeutic use. This platform approach offers potential advantages in production scalability and supply chain efficiency.